Nuveen SP SPXX posts quarterly results options overwrite strategy drives income focus for closedend fund Summit Therapeutics SMMT Stock Is It the Right Time to Invest Q4 2025 Below Expectations How emerging market exposure for The Simply SMPL Breakdown Watch 20260501 SPXC SPX Technologies falls 231 after narrow Q4 2025 EPS miss trails analyst consensus estimates